Last reviewed · How we verify

NCT05183685

a Risk Assessment and Management Program Using Telecare Consultation Among Patients With Diabetes Mellitus

Completed NA Last updated 15 September 2025
What this trial tests

NA trial testing telecare consultation in Diabetes Mellitus in 780 participants. Completed in 9 September 2025.

Timeline
10 December 2022
Primary endpoint
31 August 2025
9 September 2025

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment780
Start date10 December 2022
Primary completion31 August 2025
Estimated completion9 September 2025
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Telecare consultation, which is defined as a two-way synchronized visual (voice and image) communication between patients and healthcare professionals using telecommunication applications such as Zoom, has become a major trend in recent years. The current COVID-19 pandemic provides an impetus to drive change and increase the uptake of telecare consultation in healthcare. To the best of investigators' knowledge, there is no translational research available that simultaneously implements and evaluates the telecare model of care delivered in a primary care setting. The present study will be the first in Hong Kong to fill this service and knowledge gap in the care of DM patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Outcomes of a risk assessment and management program using telecare consultation among patients with diabetes mellitus in general out-patient clinic: a hybrid effectiveness-implementation study protocol.
    Wong AKC, Wong FKY, Liang J, Tong DWK, et al · · 2023 · cited 4× · PMID 37748120 · DOI 10.1080/07853890.2023.2262088
  2. Evaluating eRAMP telecare for diabetes in outpatient clinics: a hybrid effectiveness-implementation study.
    Wong AKC, Chen SC, Wong FKY, Liang J, et al · · 2026 · PMID 41876814 · DOI 10.1038/s41746-026-02424-9
  3. Voices from the field: healthcare professionals' insights on sustaining telemedicine for diabetes management in Hong Kong primary care.
    Wong AKC, Liu LZ, Wong FKY, Liang J, et al · · 2025 · PMID 41395628 · DOI 10.3389/fdgth.2025.1665424

Verify or expand the search:

Other trials of telecare consultation

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05183685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing